Literature DB >> 15738835

[Drug addiction and cardiovascular pathologies].

O Vandhuick1, M A Pistorius, S Jousse, N Ferreira-Maldent, J-L Guilmot, B Guias, L Bressollette.   

Abstract

Drug addiction which entails cardiovascular risks unknown or misknown to physicians, currently involves an increasing number of miscellaneous drugs, existing in manifold forms. There appears to be no bounds on the way of intake. All territories of the body may be affected with more or less severity. In young people, the cardiac, coronary, cerebral and peripheral vascular systems are generally involved. Two illicit drugs, cannabis and cocaine, showing a permanent increase in misuse, prevail. This drug addiction comes along with intercurrent pathologies which have their own vascular toxicity, especially HIV infection. Moreover, the advent of new illicit substances emphasizes the complexity of the clinical presentations. These complex situations have a real social and medical impact. We are currently in a phase of permanently increasing risk of cardiovascular complications. The pathophysiological mechanisms involved are intertwined and complicated by the frequent association of polytoxicomania or by the effects excipients added to these drugs: direct vascular toxicity, angeitis, arterial and venous thrombosis. Arsenic, a common component of these drugs, is also found in cigarettes; arsenic toxicity mainly affects the lower limbs. Treatment of these complications is non-specific; the ideal solution being weaning which, unfortunately in this peculiar population of patients, may entail serious complications due to the misuse of substitution products.

Entities:  

Mesh:

Year:  2004        PMID: 15738835     DOI: 10.1016/s0398-0499(04)96768-6

Source DB:  PubMed          Journal:  J Mal Vasc        ISSN: 0398-0499


  2 in total

1.  Cardiac arrest following cannabis use: a case report.

Authors:  Abdo H Sattout; Mark F Nicol
Journal:  Cases J       Date:  2009-11-19

2.  Pilot study of extended-release lorcaserin for cocaine use disorder among men who have sex with men: A double-blind, placebo-controlled randomized trial.

Authors:  Glenn-Milo Santos; Janet Ikeda; Phillip Coffin; John E Walker; Tim Matheson; Matthew McLaughlin; Jennifer Jain; Eric Vittinghoff; Steven L Batki
Journal:  PLoS One       Date:  2021-07-15       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.